Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reducing the physical, social, and emotional impact of episodic migraine: Results from erenumab STRIVE and ARISE phase III randomized trials

Published:2022-02 Issue:2 Volume:62 Page:159-168
ISSN:0017-8748
Container-title:Headache: The Journal of Head and Face Pain
language:en
Short-container-title:Headache

Author:

Kawata Ariane K.¹,Ladd Mary Kate¹,Lipton Richard B.²³,Buse Dawn C.²,Bensink Mark⁴,Shah Shweta⁴,Hareendran Asha⁵,Mannix Sally¹,Mikol Daniel⁶

Affiliation:

1. Evidera Bethesda Maryland USA

2. Department of Neurology Albert Einstein College of Medicine New York New York USA

3. Department of Neurology Montefiore Medical Center New York New York USA

4. Global Health Economics Amgen Inc. Thousand Oaks California USA

5. Evidera London UK

6. Global Development Amgen Inc. Thousand Oaks California USA

Funder

Amgen

Novartis

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/head.14258

Reference38 articles.

1. The Global Burden of Headache: A Documentation of Headache Prevalence and Disability Worldwide

2. Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches

3. Assessing and Managing All Aspects of Migraine: Migraine Attacks, Migraine-Related Functional Impairment, Common Comorbidities, and Quality of Life

4. Interictal burden attributable to episodic headache: findings from the Eurolight project

5. Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional impairment of chronic migraine with medication overuse: Secondary analysis from the Medication Overuse Treatment Strategy (MOTS) trial;Headache: The Journal of Head and Face Pain;2024-05-23

2. Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale;BioDrugs;2022-04-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3